Literature DB >> 14651672

Managing insomnia in the elderly - what prevents us using non-drug options?

W B Dollman1, V T LeBlanc, E E Roughead.   

Abstract

OBJECTIVE: To identify strategies needed to increase use of non-drug interventions in the management of insomnia in the elderly.
METHODS: A questionnaire was mailed to 425 general practitioners (GPs) in the South Australian Southern Division of General Practice. To provide a consumer perspective, 16 older persons attended focus groups.
RESULTS: Responses from 209 GPs showed the role of non-drug strategies in insomnia management was widely known, however access to and the usefulness of these strategies was less well known. GPs' perceptions of patients' expectations regarding medication were the greatest barrier. Patient inquiries about other options, patients' willingness to consider alternatives, printed information for patients on non-drug options, and step-by-step procedures to follow during consultations were considered enabling factors. Most consumers reported problems with sleeping but thought the GP could not help them with their sleep problems. In contrast to GPs' perceptions, consumers expressed interest in alternative treatments and willingness to participate in education sessions.
CONCLUSIONS: Strategies to increase the use of non-drug alternatives need to provide GPs with information on access to, and the usefulness of, non-drug strategies. Consumers need concurrent education to inform them that GPs can help manage insomnia, and that they need to express willingness to trial non-drug strategies. Effective communication between GPs and consumers is paramount.

Entities:  

Mesh:

Year:  2003        PMID: 14651672     DOI: 10.1046/j.0269-4727.2003.00523.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  8 in total

1.  Why do GPs prescribe psychotropic drugs when they would rather provide alternative psychological interventions?

Authors:  A Niroshan Siriwardena
Journal:  Br J Gen Pract       Date:  2010-04       Impact factor: 5.386

2.  Patients' and clinicians' experiences of consultations in primary care for sleep problems and insomnia: a focus group study.

Authors:  Jane V Dyas; Tanefa A Apekey; Michelle Tilling; Roderick Ørner; Hugh Middleton; A Niroshan Siriwardena
Journal:  Br J Gen Pract       Date:  2010-05       Impact factor: 5.386

3.  Patient Preferences for Managing Insomnia: A Discrete Choice Experiment.

Authors:  Janet M Y Cheung; Delwyn J Bartlett; Carol L Armour; Bandana Saini; Tracey-Lea Laba
Journal:  Patient       Date:  2018-10       Impact factor: 3.883

Review 4.  Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review.

Authors:  Erin Koffel; Adam D Bramoweth; Christi S Ulmer
Journal:  J Gen Intern Med       Date:  2018-04-04       Impact factor: 5.128

Review 5.  A Systematic Review and Meta-Synthesis of Patients' Experiences and Perceptions of Seeking and Using Benzodiazepines and Z-Drugs: Towards Safer Prescribing.

Authors:  Coral Sirdifield; Susan Y Chipchase; Sara Owen; Aloysius Niroshan Siriwardena
Journal:  Patient       Date:  2017-02       Impact factor: 3.883

6.  The lesser evil? Initiating a benzodiazepine prescription in general practice: a qualitative study on GPs' perspectives.

Authors:  Sibyl Anthierens; Hilde Habraken; Mirko Petrovic; Thierry Christiaens
Journal:  Scand J Prim Health Care       Date:  2007-12       Impact factor: 2.581

7.  Reducing hypnotic use in insomnia management among Australian veterans: results from repeated national interventions.

Authors:  Lisa M Kalisch Ellett; Renly Lim; Nicole L Pratt; Mhairi Kerr; Emmae N Ramsay; Tammy V LeBlanc; John D Barratt; Elizabeth E Roughead
Journal:  BMC Health Serv Res       Date:  2018-08-09       Impact factor: 2.655

8.  People with insomnia: experiences with sedative hypnotics and risk perception.

Authors:  Janet M Y Cheung; Delwyn J Bartlett; Carol L Armour; Jason G Ellis; Bandana Saini
Journal:  Health Expect       Date:  2015-08-03       Impact factor: 3.377

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.